CHARACTERIZATION OF BINDING-SITES FOR [I-125] R(+)TRANS-7-OH-PIPAT IN RAT-BRAIN

被引:0
作者
KUNG, MP [1 ]
CHUMPRADIT, S [1 ]
FREDERICK, D [1 ]
GARNER, S [1 ]
BURRIS, KD [1 ]
MOLINOFF, PB [1 ]
KUNG, HF [1 ]
机构
[1] UNIV PENN,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19104
关键词
RADIOIODINATED LIGAND; DOPAMINE D3 RECEPTORS; DOPAMINE D2 HIGH-AFFINITY STATES; AUTORADIOGRAPHY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Binding characteristics of a novel radioiodinated ligand, [I-125]R(+)trans-7-hydroxy-2-(N-n-propyl-N-3'-iodo-2'-propenyl) aminotetralin ([I-125]R(+)trans-7-OH-PIPAT), were evaluated using homogenate binding and autoradiographic techniques in rat brain. [I-125]R(+)trans-7-OH-PIPAT bound to sites (dopamine receptors) in homogenates of rat basal forebrain (including caudate putamen, nucleus accumbens and olfactory tubercle) with a high affinity (K-d = 0.42 nM). A majority (70%) of the sites labeled by [I-125]R(+)trans-7-OH-PIPAT in basal forebrain were GTP-sensitive. In rat hippocampal homogenates, specific and saturable binding of [I-125]R(+)trans-7-OH-PIPAT to 5-HT1A receptors, with a K-d value of 1.4nM and a B-max value of 210 fmol/mg protein, was observed. Binding of [I-125]R(+)trans-7-OH-PIPAT to sigma sites was also demonstrated in rat cerebellar homogenates. In the presence of GTP (to inhibit binding to D2 and 5-HT1A receptors) and DTG (to inhibit binding to sigma sites), dopamine D3 receptors could be selectively labeled with [I-125]R(+)trans-7-OH-PIPAT. [I-125]R(+)trans-7-OH-PIPAT offers several unique advantages, including high specific activity and high affinity binding, which make it an excellent probe for the investigation and characterization of the distribution of dopamine D3 receptors.
引用
收藏
页码:611 / 617
页数:7
相关论文
共 41 条
[1]  
Boundy V. A., 1993, Society for Neuroscience Abstracts, V19, P735
[2]   DEVELOPMENT OF POLYCLONAL ANTI-D2 DOPAMINE RECEPTOR ANTIBODIES TO FUSION PROTEINS - INHIBITION OF D2 RECEPTOR-G PROTEIN-INTERACTION [J].
BOUNDY, VA ;
LUEDTKE, RR ;
MOLINOFF, PB .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (06) :2181-2191
[3]  
BURRIS KD, 1994, J PHARMACOL EXP THER, V268, P935
[4]   DIFFERENCES IN THE LIGAND-BINDING PROPERTIES OF THE SHORT AND LONG VERSIONS OF THE D2 DOPAMINE RECEPTOR [J].
CASTRO, SW ;
STRANGE, PG .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (01) :372-375
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]   SYNTHESIS AND OPTICAL RESOLUTION OF (R)- AND (S)-TRANS-7-HYDROXY-2-[N-PROPYL-N-(3'-IODO-2'-PROPENYL)AMINO]TETRALIN - A NEW D3 DOPAMINE-RECEPTOR LIGAND [J].
CHUMPRADIT, S ;
KUNG, MP ;
KUNG, HF .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (26) :4308-4312
[7]  
CIVELLI O, 1993, ANN REV PHARM TOXICO, V32, P281
[8]   SYNTHESIS OF (R,S)-2'-TRANS-7-HYDROXY-2-[N-N-PROPYL-N-(3'-IODO-2'-PROPENYL)-AMINO]TETRALIN (TRANS-7-OH-PIPAT) - A NEW D3-DOPAMINE RECEPTOR-LIGAND [J].
FOULON, C ;
KUNG, MP ;
KUNG, HF .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) :1499-1500
[9]   [I-125] (S)-TRANS-7-OH-PIPAT - A POTENTIAL SPECT IMAGING AGENT FOR SIGMA-BINDING SITES [J].
GARNER, SE ;
KUNG, MP ;
FOULON, C ;
CHUMPRADIT, S ;
KUNG, HF .
LIFE SCIENCES, 1994, 54 (09) :593-603
[10]   AUTORADIOGRAPHIC LOCALIZATION OF [H-3] QUINPIROLE BINDING TO DOPAMINE-D2 AND DOPAMINE-D3 RECEPTORS IN RAT-BRAIN [J].
GEHLERT, DR ;
GACKENHEIMER, SL ;
SEEMAN, P ;
SCHAUS, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 211 (02) :189-194